Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
weight drugs
Biotech
Viking's GLP-1 spurs steep weight loss, sending shares up 80%
Viking has plenty to celebrate after its dual agonist of GLP-1 and GIP was linked to weight loss of up to 14.7% after 13 weeks of treatment.
Nick Paul Taylor
Feb 27, 2024 10:15am
AstraZeneca CEO: GLP-1 focus is weight management, not obesity
Nov 10, 2023 12:08pm
This cancer-related gene may also help combat obesity
May 22, 2020 8:35am
Sanofi inks €250M bispecific small molecule diabetes deal
May 9, 2017 3:00am
Zafgen starts comeback with data on new weight-loss drug
May 5, 2017 8:00am
Zafgen ditches lead candidate after deaths, clinical hold
Jul 19, 2016 6:37pm
